Karmanos, WSU SOM scientists receive Strategic Research Initiative Grants for promising research
Monday, August 26, 2013
The Barbara Ann Karmanos Cancer Institute has announced the winners of its 2013 Strategic Research Initiative Grants, which fund innovative intra- and inter-programmatic projects, which exhibit great potential in leading to multi-investigator grants.
A total of four $50,000 grants have been given to researchers. These grants last for one year.
Winners of the grants include:
- Rafael Fridman, Ph.D., professor in the Cancer Biology Graduate Program at Karmanos and Wayne State University School of Medicine (WSU SOM) and Bonnie Sloane, Ph.D., distinguished professor and chair for the Department of Pharmacology at Karmanos and WSU SOM, for their project, “Discoidin Domain Receptors and Collagen Density: Unveiling the Biological Bases for the Relationship between Mammographic Density and Breast Cancer Risk.”
- Aliccia Bollig-Fisher, Ph.D., assistant professor in the Department of Oncology at Karmanos and WSU SOM, and Sandeep Mittal, M.D., FRCSC, co-leader of the Neuro-oncology Multidisciplinary Team at Karmanos and WSU SOM, for their project, “Identification of candidate driver oncogenes from cytogenomic analysis of metastatic brain tumors.”
- Larry Lum, D.SC., professor of Medicine and Immunology and Microbiology at Karmanos and WSU SOM and Shelley Seward, M.D., member of the Gynecologic Oncology Multidisciplinary Team at Karmanos and WSU SOM, for their project “Vaccinating with Targeted T-cells, Deleting Tregs, and Boosting with Immune T-cells for Optimizing Immunotherapy Against Ovarian Cancer.”
- Elisabeth Heath, M.D., F.A.C.P., director of Prostate Cancer Research and professor of Oncology and Medicine at Karmanos and WSU SOM and Avraham Raz, Ph.D., professor in the Department of Oncology at Karmanos and WSU SOM, for their study, “A Pilot Study of the Role of Galectin-3 in Prostate Cancer Screening and Diagnosis.”
“These studies are just a few examples of the truly dynamic and innovative work that takes place every day between our clinical researchers and basic scientists at Karmanos Cancer Institute and Wayne State University School of Medicine,” said Gerold Bepler, M.D., Ph.D., president and CEO of Karmanos. “These projects are truly collaborative and pave the way to new therapies that will bring hope to cancer patients in the future.
“I extend my personal congratulations to all the doctors who have received these grants.”